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Abstract
Background: General theory of anesthetic managements for nontransplant procedures in lung transplant patients
was proposed. However, there are few literatures reporting the perioperative management of thoracoabdominal
major surgery following lung transplantation in detail. Herein, we scrupulously report a perioperative management
of esophagectomy in a patient who previously underwent bilateral lung transplantation (BLTx), focusing on
protection of the transplanted lungs and the respiratory function of the patient.
Case presentation: A 50-year-old woman was listed for cadaveric BLTx for severe respiratory failure due to
end-stage diffuse panbronchiolitis. She underwent BLTx under veno-arterial extracorporeal membranous oxygenation
support. Blood loss during the BLTx was 13,675 mL, and mild lung edema developed. She was weaned from
the ventilator on the sixth postoperative day (POD) and discharged on the 65th POD. Two years after the
BLTx, respiratory function improved markedly, but she was diagnosed with esophageal cancer and was scheduled for
thoracoscopic esophagectomy with radical lymph node dissection, hand-assisted laparoscopic gastric mobilization, and
anastomosis of the gastric conduit to the cervical esophagus via posterior mediastinum. We were concerned
that impaired lymphatic drainage could cause pulmonary edema or lymphangiogenesis could cause a severe
immunologic response against the lung grafts. To avoid graft injury and rejection, we addressed lung protective
ventilation, reduced transfusion volume, continued immunosuppressive agents, administered volatile anesthetics, and
prevented dynamic pain by epidural analgesia. These factors and the improved respiratory function may have
contributed to successful management of esophagectomy. During the perioperative period, the major respiratory
problems were a slight right lung edema and a persistent pulmonary air leak due to the division of thoracic adhesions,
which resolved on 13th POD.
Conclusions: Cancer surgeries in lung transplant recipients become more common. When such patients undergo
thoracoabdominal major surgery, we should pay special attention to respiratory function, operative stress,
immunosuppressive therapy, transfusion volume for the prevention of lung edema, and thoracic adhesions.
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Background
General theory of anesthetic managements for non-
transplant procedures in lung transplant patients was
discussed [1]. However, there are few literatures report-
ing the perioperative management of thoracoabdominal
major surgery following lung transplantation in detail.
And then, we managed an esophagectomy with radical
lymph node dissection in a patient who previously
underwent bilateral lung transplantation (BLTx). Dur-
ing the perioperative period of the esophagectomy, de-
terioration of expectoration and lung edema followed
by respiratory dysfunction, and graft rejection were is-
sues. Herein, we scrupulously report the perioperative
management of the esophagectomy following BLTx, fo-
cusing on protection of the transplanted lungs and the
respiratory function of the patient.
Case presentation
A 50-year-old female patient was listed for cadaveric
BLTx for end-stage diffuse panbronchiolitis. Her respira-
tory function was severely impaired and echocardiog-
raphy indicated secondary pulmonary hypertension
(Table 1). Chest radiography and computed tomography
(CT) showed significant diffuse emphysematous changes
in all lung fields (Fig. 1). She underwent BLTx under
veno-arterial extracorporeal membranous oxygenation
(V-A ECMO) support. Blood loss during the BLTx
amounted to 13,675 mL, and mild lung edema developed.
Therefore, her chest was closed on the fourth postopera-
tive day (POD). She was weaned from the ventilator on
the sixth POD and discharged ambulatory without oxygen
on the 65th POD.
Two years after the BLTx, the follow-up chest CT
findings suspected esophageal cancer, and the patient
was diagnosed with stage II esophageal cancer via eso-
phagogastroduodenoscopy. Three months later, she was
scheduled for thoracoscopic esophagectomy with rad-
ical lymph node dissection, hand-assisted laparoscopic
gastric mobilization, and anastomosis of the gastric con-
duit to the cervical esophagus via posterior mediastinum.
She was 147 cm tall and weighed 35 kg. Before esoph-
agectomy, her respiratory function was normal and her
echocardiography indicated disappearance of secondary
pulmonary hypertension and subsequent increased left
ventricular preload (Table 1). Chest radiography and
CT showed normalized lung fields (Fig. 2), but postop-
erative intrathoracic adhesions were suspected. Her
preoperative blood examination detected no abnormal
values except for a slightly elevated plasma creatinine
concentration of 1.02 mg/dL and decreased hemoglobin
concentration of 9.8 g/dL. And white blood cell (WBC)
counts was 4100 /μL, and serum C-reactive protein
(CRP) level was 0.1 mg/dL. She was treated with im-
munosuppressive agents including 1.6 mg/day of tacro-
limus (blood concentration was 6.0 ng/mL), 500 mg/day
of mycophenolate mofetil, and 5 mg/day of prednisolone,
with 0.625 mg/day of bisoprolol for the suppression of
right heart function. On the morning of surgery, she was
administered 500 mg of methylprednisolone intravenously
for the prevention of rejection and relative adrenal insuffi-
ciency. In the operating room, a thoracic epidural catheter
was placed at the level of the T9–T10 intervertebral space.
Before anesthesia induction, arterial catheter was inserted
and then phenylephrine infusion (0.25 μg/kg/min) was ini-
tiated to prevent hypotension induced by anesthetic
agents. After oxygenation, general anesthesia was induced
by continuous infusion of remifentanil (0.5 μg/kg/min),
intravenous bolus administrations of propofol (20 mg),
and rocuronium (30 mg). She was orotracheally intubated
with a 35 French double-lumen endobronchial tube. Due
to the significant incidence of complications on bronchial
anastomosis, endobronchial tube was positioned with
fiberoptic bronchoscopic guidance. After intubation, cen-
tral venous catheter was inserted via left basilic vein and
the monitoring of central venous pressure (CVP) was
started. During induction and intubation, hemodynamic
and respiratory status remained stable. She received
pressure-controlled ventilation with a fraction of inspired
oxygen (FIO2) of 0.3–0.45, positive end-expiratory pres-
sure (PEEP) of 5 cmH2O, peak inspiratory pressure (PIP)
of less than or equal to 18 cmH2O, and respiratory rate
(RR) of 10–18/min. During two-lung ventilation, the
Table 1 Arterial blood gas, spirometric, and echocardiographic
data of the patient before BLTx and before esophagectomy
Before BLTx Before MIE
Arterial blood gases on room air
PaO2 (mmHg) 51 99
PaCO2 (mmHg) 49 44
SaO2 (%) 86 98.5
Spirometry
FVC (mL) 900 2050
%FVC (%) 36.0 83.3
FEV1.0 (mL) 640 1960
%FEV1.0 (%) 71.1 95.6
Echocardiography
LVEDd (mm) 31 41
LVEF (%) 77 75
TRPG (mmHg) 69 16
Others TR II° TR I°
BLTx bilateral lung transplantation, MIE minimally invasive esophagectomy,
PaO2 arterial oxygen tension, PaCO2 arterial carbon dioxide tension, SaO2
arterial oxygen saturation, FVC forced vital capacity, %FVC percent-predicted
FVC, FEV1.0 forced expiratory volume in one second, %FEV1.0 percent-
predicted FEV1.0, LVEDd left ventricular end-diastolic diameter, LVEF left ven-
tricular ejection fraction, TRPG maximum tricuspid regurgitation pressure gradi-
ent, TR tricuspid valve regurgitation
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dynamic compliance (Cdyn) and the arterial oxygen
tension to FIO2 ratio (P/F) of her lungs were approxi-
mately 30 mL/cmH2O and more than 500, respectively,
and the CVP was 4–8 mmHg. Anesthesia was maintained
by desflurane (3.5 %) and remifentanil (0.5–0.7 μg/kg/min),
with continuous epidural analgesia using 0.25 % levobupi-
vacaine (4 mL/h). Phenylephrine (0.1–0.4 μg/kg/min) and
noradrenaline (0.03–0.04 μg/kg/min) infusion were used to
prevent hypotension and overhydration, and sivelestat infu-
sion (0.4 mg/kg/h) and carperitide infusion (10 ng/kg/min)
were used to reduce lung injury and extravascular lung
water. She was placed in the left lateral position and thora-
coscopic esophagectomy with radical lymph node dissec-
tion was started. One-lung ventilation and an artificial
pneumothorax, insufflating with carbon dioxide gas (CO2)
to promote lung collapse, were started, and then the CVP
increased to 12–18 mmHg. During the thoracic procedure,
the Cdyn and P/F of her lung were 15–20 mL/cmH2O and
273–421, respectively, with PaCO2 and serum lactate level
elevated up to 63 mmHg and 2.7 mg/dL, respectively. Arti-
ficial pneumothorax was prolonged (396 min), because of
extensive intrathoracic adhesions, and a pulmonary air leak
persisted after the thoracic procedure. After that, two-lung
ventilation was resumed, and she was placed in the lithot-
omy position for abdominal and cervical procedure. Her
CVP decreased to 4–7 mmHg. Hand-assisted laparoscopic
gastric mobilization was started, which increased the CVP
to 10–12 mmHg, transiently. Then, the gastric conduit was
anastomosed with the cervical esophagus via the posterior
mediastinum and a jejunostomy tube was placed for
enteral feeding. One hour before the completion of the sur-
gery, desflurane was discontinued, propofol (4 mg/kg/h)
was started, and remifentanil was reduced to 0.3 μg/kg/
min. After the completion of the surgery, bronchoscopy
and arterial blood gases confirmed the preservation of
bronchial blood flow and pulmonary function, and main-
tenance anesthetics and phenylephrine were discontinued.
She recovered from the anesthesia and her tracheal tube
Fig. 1 Chest radiography (a) and computed tomography (b) images of the patient before bilateral lung transplantation. a Significant
diffuse emphysematous changes are seen on all lung fields. b Diffusely enhanced interstitial opacity on lung fields and an emphysematous bulla on
the left lung are seen
Fig. 2 Chest radiography (a) and computed tomography (b) images of the patient before minimally invasive esophagectomy. a Normalized lung
fields, and sternal wires and marking clips on mediastinal field are seen. b Normalized lung fields and marking clips on the esophagus are seen
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was removed. Duration of the surgery and anesthesia were
669 min and 760 min, respectively. Blood loss and urine
volume during anesthesia were 217 mL and 775 mL, re-
spectively. We infused with 550 mL of 6 % hydroxyethyl
starch 130/0.4 solution, 500 mL of amino acid solution,
650 mL of saline, and 120 mL of acetated Ringer’s solution
during anesthesia. At the completion of the surgery, her
serum creatinine and lacate values were 1.4 mg/dL
and 2.1 mg/dL. Subsequently, she was transferred to
the intensive care unit with continuous epidural anal-
gesia of 4 mL/h of levobupivacaine 0.25 % + fentanyl
2.5 μg/mL and patient controlled epidural analgesia
of bolus 3 mL (30-min lock out).
On the first POD, WBC count and CRP level were
elevated to the level indicating moderate-to-intense
inflammatory reaction, and the CVP remained 4–6 mmHg.
Table 2 shows the changes of her WBC counts, serum
CRP, creatinine and lactate levels, and water balance dur-
ing perioperative period. Intravenous methylprednisolone
125 mg, cyclosporin infusion (2 mg/h, 250–300 ng/mL of
target blood concentration), and enteral mycophenolate
mofetil (500 mg/day) were administered. And nor-
adrenaline was discontinued. On the second POD, her
inflammatory reaction was persisted. Cyclosporin infusion
was discontinued and enteral tacrolimus (1.6 mg/day,
8–10 ng/mL of target blood concentration) was initi-
ated. On the third POD, her body weight increased to
a maximum value of 37.7 kg due to daily positive
water balance, and chest radiography and CT showed
slight pulmonary edema and pneumothorax in the
right lung field (Fig. 3). However, her inflammatory reac-
tion attenuated and CVP increased to 14–18 mmHg. Sive-
lestat infusion was discontinued and blood concentration
of tacrolimus was 7.4 ng/mL. On the fourth POD, her
body weight decreased to 36.7 kg and CVP decreased to
10–12 mmHg due to a beginning of intravascular refilling
and diuretic phase. On the ninth POD, moderate inflam-
matory reaction was continued and her blood concen-
tration of tacrolimus was maintained within 9.0 to
11.7 ng/mL. And she started oral dietary intake. On
the 11th POD, carperitide was discontinued. On the
13th POD, inflammatory reaction diminished. And
her chest drainage tube was removed and intravenous
methylprednisolone was tapered slowly and then dis-
continued. She was discharged ambulatory without
oxygen on the 29th POD. Before discharge, chest
radiography and CT showed the disappearance of pul-
monary edema and pneumothorax (Fig. 4).
Discussion
Solid organ transplant recipients have elevated cancer
risk due to immunosuppression [2, 3]. As a result, can-
cer surgeries in lung transplant recipients may increase
along with the increase in lung transplants. During these
surgeries, protection of the lung graft is the top priority,
because the 5-year survival for the recipients of cadav-
eric donor lung transplants is approximately 50 % [4],
which is significantly lower than that of other organ
transplants but similar to that of patients with stage II
esophageal cancer.
During lung transplantation, anastomosis of donor
lymphatic vessels to those of the recipient is not
performed. Therefore, pulmonary edema and acute re-
jection readily occur for several days after transplant-
ation. The graft lymphatics establish new connections
with regional lymph nodes no earlier than at least 7 days
[5, 6]. Subsequently, lymphatic drainage would remove
excess lung fluid and damaging substances, which would
improve graft outcome [7]. However, the extent of lym-
phangiogenesis after transplantation might correlate
with the magnitude of donor antigen presentation and
may influence the severity of the immunologic response
against the donor organ [8, 9]. Therefore, we took great
care to avoid enhancement of her immunological
response, which could induce graft injury and rejection.
The measures were as follows: (1) lung protective ventila-
tion with FIO2 ≤ 0.6, PEEP = 5 cmH2O, PIP ≤ 18 cmH2O;
(2) the continuation of immunosuppressive agents and
loading of methylprednisolone during the perioperative
period; (3) neutrophil elastase inhibitor (sivelestat)
Table 2 Postoperative white blood cell counts, serum C-reactive protein, creatinine and lactate levels, and water balance during
perioperative period
POD −1 0 1 2 3 5 6 9 13 29
WBC (/μL) 4100 29,600 16,000 19,000 12,800 11,000 10,800 11,000 7000 7300
CRP (mg/dl) 0.1 – 5.4 4.0 1.7 1.3 1.1 0.6 0.7 0.1
Creatinine (mg/dl) 1.02 1.4 1.1 1.0 1.0 0.86 1.0 1.18 1.16 1.03
Lactate (mg/dl) 1.3 2.1 1.57 1.06 1.0 – – – – –























Body weight (kg) 35.0 – 35.1 36.6 37.7 36.7 36.5 35.9 35.8 –
POD postoperative day after esophagectomy, WBC white blood cell counts, CRP serum C-reactive protein level
Toyama et al. JA Clinical Reports  (2016) 2:15 Page 4 of 7
infusion; (4) use of volatile anesthetics (desflurane) pre-
venting inflammation for the maintenance of anesthesia
[10]; and (5) adequate control of pain using epidural
analgesia. Neuraxial anesthesia is considered to facilitate
coughing, expectoration, and active mobilization, and pre-
vent atelectasis and respiratory infections, although neur-
axial anesthesia reduce intercostal muscle strength.
Furthermore, thoracic epidural analgesia blocks sym-
pathetic nervous system, which inhibits inflammatory
reaction supplementarily. Although these measures
were used, inflammatory reaction raised maximum
level (WBC 19,000/μL and CRP 5.4 mg/dL), indicating
moderate-to-intense inflammatory reaction, on the first to
second POD and continued until the 13th POD. There-
fore, slight right lung edema was observed but graft injury
and rejection were not observed.
Transplanted lungs are highly susceptible to fluid over-
load over a long period. Lymphatic interruption increases
the risk of extravascular lung water accumulation [11] and
it may be responsible for pulmonary edema development
following even minimal fluid overload [12]. In this case,
lymph node dissection, which removed newly established
graft lymphatics, division of thoracic adhesions, and the
placement of gastric conduit, which passed through the
right posterior mediastinum, were performed. These pro-
cedures had the potentials to induce interstitial lung
edema and subsequent pulmonary dysfunction, because of
encouraging inflammation of lung tissue, hemorrhage,
prolonged surgery, and increased transfusion. To reduce
the transfusions and maintain low central venous
pressure, which inhibit the increase in interstitial lung
water [13], we used phenylephrine and noradrenaline
Fig. 3 Chest radiography (a) and computed tomography (b) images of the patient on the 3rd postoperative day. a Chest drainage tube,
permeability decay, and expansion failure on the right lung fields, subcutaneous emphysema on the right chest wall, drainage tube and
gastric conduit on the mediastinal field, and peripheral venous nutrition tube on the left arm are seen. b Chest drainage tube, moderate
pleural effusion, and expansion failure on the right lung, and small pleural effusion on the left lung are seen
Fig. 4 Chest radiography (a) and computed tomography (b) images before discharge. a Reexpanded right lung and gastric conduit on the
mediastinal field are seen. b Reexpanded right lung, disappearance of pleural effusion, and gastric conduit on the right posterior mediastinum
are seen
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for maintenance of adequate blood pressure, and carperi-
tide for excretion of excess lung fluid during anesthesia.
These treatments may have contributed to prevent further
deterioration of the right lung edema and the progression
to pulmonary dysfunction or rejection. In this case, we
monitored arterial blood pressure and CVP for the assess-
ment of hemodynamics, but CVP, fluctuating with
changes of intrathoracic pressure, was inaccurate
index of cardiac preload. Therefore, transpulmonary
thermodilution technique might be better to assess
the hemodynamics of patients like this case. But we
did not use transpulmonary thermodilution technique
in this case, because the cardiac function of the pa-
tient was normal and lithotomy position during ab-
dominal manipulation could cause femoral arterial
catheter kinking, although the measurement of extra-
vascular lung water and pulmonary vascular perme-
ability index would be useful in the postoperative
managements of the patient. Furthermore, the reduc-
tion in blood flow to her bronchi during esophagec-
tomy was of concern because the bronchial arteries
had been eliminated from her lung. However, bron-
choscopy during perioperative surgery showed the
preservation of blood flow to her bronchi. Whereas,
intravascular refilling and diuretic phase occurred in
comparatively later POD (during the third POD and
fourth POD). This might be because the dissection of
the lung graft lymph node impaired the lymphatic
drainage and removal of excess lung fluid.
The respiratory function of this patient improved sig-
nificantly after BLTx. In two-lung ventilation during
esophagectomy, her Cdyn, P/F, and ratio of dead space
to tidal volume were within normal limit (30 mL/H2O,
500, and 0.15, respectively). Therefore, ventilatory insuf-
ficiency did not occur during artificial pneumothorax
and pneumoperitoneum, although her PaCO2 was ele-
vated transiently. However, in patients with single lung
transplantation and/or poor lung graft function, ventila-
tory insufficiency might occur, which promotes ventilator-
induced lung injury and an inflammatory reaction,
followed by pulmonary dysfunction and graft rejection.
During the perioperative period of esophagectomy, the
major respiratory problems of this case were a slight right
lung edema and a persistent pulmonary air leak due to the
division of the thoracic adhesions, which needed 13 days
to recover.
Conclusions
We report the perioperative management of a patient
receiving esophagectomy who previously underwent
BLTx. Cancer surgeries in lung transplant recipients
increase. When such patients undergo thoracoabdom-
inal major surgery as this case, we should pay special
attention to respiratory function, operative stress,
immunosuppressive therapy, volume of transfusion for
prevention of lung edema, and thoracic adhesions.
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